WACC. Grey's Pharmaceuticals has a new project that will require funding of $12.3 million. The company has decided to pursue an all-debt scenario. Grey's has made agreements with four lenders for the needed financing. These lenders will advance the following amounts at the interest rates shown: Click on the Icon in order to copy its content into a spreadsheet. Amount Interest Rate Lender Steven Yang Shepherd Bailey $4,592,837 $3,672,217 $2,544,955 $1,489,991 13% 12% 9% 10% What is the weighted average cost of capital for the $12,300,000